Aviva plc (LON:AV.)
London · Delayed Price · Currency is GBP · Price in GBX 666.40
-2.20 (-0.33%)
At close: Nov 3, 2025
Aviva Revenue
Aviva had revenue of 12.37B GBP in the half year ending June 30, 2025, with 26.53% growth. This brings the company's revenue in the last twelve months to 24.26B, up 7.10% year-over-year. In the year 2024, Aviva had annual revenue of 22.74B with 5.36% growth.
Revenue (ttm)
24.26B
Revenue Growth
+7.10%
P/S Ratio
0.83
Revenue / Employee
833.97K
Employees
29,091
Market Cap
20.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.74B | 1.16B | 5.36% |
| Dec 31, 2023 | 21.58B | 5.38B | 33.20% |
| Dec 31, 2022 | 16.20B | -459.00M | -2.75% |
| Dec 31, 2021 | 16.66B | -9.18B | -35.53% |
| Dec 31, 2020 | 25.84B | -17.11B | -39.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |